Validity of melanoma diagnosis in a community-based screening program

Area of Science:

• Dermatology
• Oncology
• Public Health

Background:

• Melanoma screening is intuitively appealing but lacks robust evidence of effectiveness for skin cancer.
• The Lions Cancer Institute has conducted full-body skin screening clinics in Western Australia since 1990.

Purpose of the Study:

• To evaluate the diagnostic validity of full-body skin screening for melanoma.
• To assess the sensitivity and specificity of skin cancer screening diagnoses.
• To determine the impact of lesion body site on screening accuracy.

Main Methods:

• Analysis of data from 7,436 individuals screened between 1994 and 2002.
• Linking screening data with the Western Australian Cancer Registry to identify melanoma diagnoses.
• Calculation of positive predictive value, sensitivity, and specificity, considering body site.

Main Results:

• The positive predictive value for a screening diagnosis of melanoma was 10.0%.
• One-year specificity ranged from 95.1% to 99.5%, and sensitivity ranged from 63.6% to 81.8%.
• Sensitivity decreased at two years, and considering body site improved diagnostic validity.

Conclusions:

• Skin cancer screening diagnoses demonstrate reasonable validity in the general population.
• The location of a lesion is a critical factor in accurately assessing screening test validity.
• Further research is needed to establish the overall effectiveness of melanoma screening programs.